KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.
about
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
KEMTUB012-NI2, a novel potent ...... p450 reductase downregulation.
@en
KEMTUB012-NI2, a novel potent ...... p450 reductase downregulation.
@nl
type
label
KEMTUB012-NI2, a novel potent ...... p450 reductase downregulation.
@en
KEMTUB012-NI2, a novel potent ...... p450 reductase downregulation.
@nl
prefLabel
KEMTUB012-NI2, a novel potent ...... p450 reductase downregulation.
@en
KEMTUB012-NI2, a novel potent ...... p450 reductase downregulation.
@nl
P2093
P2860
P356
P1476
KEMTUB012-NI2, a novel potent ...... p450 reductase downregulation.
@en
P2093
Ian N Fleming
Marco Spiga
Matteo Zanda
Monica Sani
Paolo Lazzari
P2860
P356
10.2147/HP.S132832
P577
2017-05-23T00:00:00Z